1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6A1BF1D940B6810E9002585880045DE50
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-developing-superior-global-quality-assurance-operations-staffing-investment?opendocument
18
19opendocument
203.237.186.116
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Quality, Compliance and Regulatory Structure,Staffing and Execution

Developing Superior Global Quality Assurance Operations: Staffing and Investment

ID: 5619


Features:

3 Info Graphics

18 Data Graphics

230+ Metrics


Pages/Slides: 28


Published: 2020


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from “Developing Superior Global Quality Assurance Operations: Staffing and Investment”

STUDY OVERVIEW

Pharmaceutical and medical device companies allocate a considerable amount of resources to ensure their products meet quality standards at every stage of the product life cycle, from R&D and product development through manufacturing, sale, and post-market support.

Consequently, Quality Assurance leadership faces a complex balancing act between managing resources, ensuring product quality and compliance, and delivering value to patients and healthcare providers.

Best Practices, LLC conducted this benchmarking research to probe how leading pharmaceutical and medical device companies are using Quality Assurance staffing and investment to meet company and marketplace demands. This study benchmarks the staffing, budget, and spending levels of Global Quality Assurance functions.


KEY TOPICS

  • Quality Assurance Staffing
  • Quality Assurance Investment

KEY METRICS
  • Please estimate the total number of FTEs that work in different parts of your company's Quality Assurance functional area
  • Estimate the average number of direct reports at each supervisory level in your organization by area during 2019
  • How has your functional area headcount changed in the past 3 years?
  • What forces or issues have been driving the percentage changes in your company's functional staffing and spending during the past three years?
  • How has the total Spend of your company's Quality functional spending changed over the past 3 years?
  • How would you describe your level of agility when integrating new M&A into your business operations?

SAMPLE KEY FINDINGS
  • Quality Assurance Spend: Quality Assurance spend typically does not exceed 1% of total annual revenue at all organizations.

METHODOLOGY

Best Practices, LLC engaged 24 leaders from 22 life sciences and medical device companies in this research through a benchmarking survey. More than 80% of the benchmark class serves at the director level and above.


Industries Profiled:
Medical Device; Biopharmaceutical; Pharmaceutical; Medical; Technology; Research; Health Care; Biotech; Science


Companies Profiled:
3M - DDSD; Acceleron Pharma; Aesculap; Anesthetics Biomedical Inc.; Biotronik; Boston Scientific; Grifols; Halma; inStem; Johnson & Johnson; Lentigen Technology; Inc.; Minnetronix; NeedleTech Products Inc.; Onconova Therapeutics; PerkinElmer; Quest Medical; Radius Health; ReShape Lifesciences; Sartorius Stedim; Thermo Fisher Scientific; Verastem Oncology; Waters Corporation

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.